ClinicalTrials.gg
Sign In

Appendiceal Neoplasms clinical trials

The registry lists 86 studies for Appendiceal Neoplasms across more than 10 countries. 25 are recruiting or about to start. 28 of them are mainly about Appendiceal Neoplasms (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-10.

Get an email when these change. Save the Appendiceal Neoplasms studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
40
Recruiting
24
Active, not recruiting
9
Status unknown
5
Terminated
5
Withdrawn
2

Phase

Phase 1
29
Phase 2
22
Phase 3
4
Phase 4
2

Where

United States
66
France
7
Spain
4
Netherlands
4
Italy
3
China
3

Who runs them

National Cancer Institute (NCI) (9) · Wake Forest University Health Sciences (6) · M.D. Anderson Cancer Center (3) · City of Hope Medical Center (3) · Memorial Sloan Kettering Cancer Center (3) · Dartmouth-Hitchcock Medical Center (3) · Case Comprehensive Cancer Center (2) · Revolution Medicines, Inc. (2)

What is being tested here

Drugs under test in Appendiceal Neoplasms studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Mitomycin418
Oxaliplatin2010
Fluorouracil204
Cisplatin203
Doxorubicin202
Irinotecan106
Leucovorin102
Elironrasib102
Melphalan102
KRAS G12D Inhibitor VS-7375101

Drug classes tested here Alkylating agents 5 open · Antimetabolites 2 open · Tyrosine kinase inhibitors (TKIs) 1 open

Coming up

1phase 3 study under way
9studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 9

Who these studies take

Of the 24 Appendiceal Neoplasms studies recruiting now, 17 (71%) set no upper age limit and 4 (17%) stop at 75 or younger. 2 (8%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 2 (8%) take healthy volunteers.

Recruiting studies that take each age, of 24
AgeWomenMen
102 (8%)2 (8%)
1823 (96%)23 (96%)
3023 (96%)23 (96%)
4023 (96%)23 (96%)
5023 (96%)23 (96%)
6523 (96%)23 (96%)
7522 (92%)22 (92%)
8519 (79%)19 (79%)

Across all 86 studies, recruiting or not: 6% stop at 75 or younger and 2% at 65; 13% take children; 0% are for women only and 0% for men only; 5% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

Studies

Recruiting first, then most recently updated. Showing 50 of 86. Browse all 86 → or search them.